Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
about
The spectrum of SWI/SNF mutations, ubiquitous in human cancersThe anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complexNCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomesAre we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?A landscape of driver mutations in melanomaMutational heterogeneity in cancer and the search for new cancer-associated genesEpimutational profile of hematologic malignancies as attractive target for new epigenetic therapiesTargeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectivesCurrent challenges and novel treatment strategies in double hit lymphomasMEF2 transcription factors: developmental regulators and emerging cancer genesEZH2 in normal hematopoiesis and hematological malignanciesMutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomasNext-generation prognostic assessment for diffuse large B-cell lymphomaChemical probes of histone lysine methyltransferasesCombating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaThe Yin and Yang of Toll-like receptors in cancerThe epigenetic basis of diffuse large B-cell lymphomaThe genetic landscape of diffuse large B-cell lymphomaHistone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and preventionSWI/SNF chromatin remodeling complexes and cancerEmerging patterns of somatic mutations in cancerChromatin signatures of cancerNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewStructural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET DomainWhole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Lymphoma: immune evasion strategiesHistone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancyTargeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell LymphomaNegative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 GenesAID targeting: old mysteries and new challengesDiscovery and saturation analysis of cancer genes across 21 tumour typesExome sequencing identifies BRAF mutations in papillary craniopharyngiomasAge-related clonal hematopoiesis associated with adverse outcomesAn ImmunoChip study of multiple sclerosis risk in African Americans.Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.The genetic landscape of mutations in Burkitt lymphoma.PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data.DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.Integration of genomic data enables selective discovery of breast cancer drivers.
P2860
Q21090801-195909FC-31A9-4619-944B-1B88B1E95A80Q24306032-4693F797-4A6F-4B5A-A180-57FFD05BC198Q24596715-94F346B0-DD1D-4773-9018-20968FC36DD8Q24597424-CCD33F31-753E-49C0-AC7E-F71F29AD5049Q24603357-F96201BD-850C-487D-B7C3-59D1FF614FE6Q24606956-302DD07D-3971-4E75-9CD5-44FEB2C34ED7Q26744080-228D6AA4-D233-475A-A69A-FAD59D4F7312Q26744441-E803F650-8195-4D26-BCB6-29AF525B452EQ26770385-F00FFD31-6C7E-4545-B2C7-3161297E007EQ26778515-C6B17B34-03C3-46B0-94FD-A0534A35B4ECQ26779821-A2B44D9C-2E9A-41FE-A5E7-676984D3C010Q26782506-E6BF42BF-2944-4D0A-839A-4408D6406F43Q26796428-9C44D399-8B6F-4E54-821C-06750CFD8010Q26829218-368315B4-8E38-4B1B-BC93-4751883CCC9EQ26851166-5F0500CD-1CE3-4426-B478-C1CF2C42878BQ26851526-760BE072-423F-41BE-BEBB-1621BB040A4FQ26852288-7A64829B-AEA2-431F-BEA0-94EC60244E63Q26866537-826A159F-6EAA-43CD-A1B1-C876B9CCFF49Q26994739-56EA870E-6E25-4E13-8BF6-07928FF5155AQ26998657-0A6713A2-767E-4CC5-848D-8817C15985D3Q27014126-6E508895-505A-4E8B-89C3-B2E70786859EQ27024162-D72B5D98-4DE4-4B75-AB5E-C7F39761F129Q27304386-6B5A80CC-1D2D-409B-8295-01EADDE705F6Q27681087-405F63DE-C1EB-4FCA-AFE4-9BEAB7C0BE3FQ27853005-F252D606-F840-4964-A393-7AE3EA53E169Q28080705-8DED5A01-34AA-4770-A035-BD45E26E3B5DQ28082536-601E01EE-89A2-442B-96E2-FEA903CB8301Q28115962-78C59B37-6AD0-4E24-A140-347DB8717722Q28117437-D44917B9-FE35-4DAB-BCA2-379EBFF489ABQ28261895-DB982A98-51B3-4ABE-B566-9A70CDC23503Q28265992-6A951DD9-A981-4F50-90D6-D1641A89C0A8Q28305204-221D4D4A-BDAD-42E4-B804-E22FC3CE6B33Q28305680-464DE654-8F45-4B69-9470-E2A350BA5575Q28386602-DCE9DC79-7924-458F-BA0E-F6659B594E56Q30300285-06224793-34A2-497F-8BB4-2D81374D6207Q30411902-95547E75-A7D2-4995-96BC-81429122C548Q30453771-813B5887-BAFD-46D3-B3E0-53911FEE3F76Q30827643-27C9DDBD-5BB9-49EF-8BB8-C98271EE7FB9Q30837199-7B01697D-BB9D-4BD1-91ED-62A0A137BAB7Q30872438-C03432B8-6577-4102-9D7A-31CB7B66A0BB
P2860
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@ast
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@en
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@nl
type
label
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@ast
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@en
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@nl
prefLabel
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@ast
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@en
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@nl
P2093
P2860
P50
P3181
P356
P1476
Discovery and prioritization o ...... BCL) by whole-exome sequencing
@en
P2093
Ahmet Dogan
Angela Schwarz-Cruz y Celis
Birgit Knoechel
Bjoern Chapuy
Chandra S Pedamallu
Claudia Rangel-Escareño
Enrique Hernández-Lemus
Ivan Imaz-Rosshandler
Jens G Lohr
Joonil Jung
P2860
P304
P3181
P356
10.1073/PNAS.1121343109
P407
P50
P577
2012-03-06T00:00:00Z